For the quarter ended September 2026, Health Catalyst (HCAT Quick QuoteHCAT - Free Report) reported revenue of $56.28 million, down 26.3% over the same period last year. EPS came in at -$0.03, compared to $0.06 in the year-ago quarter.

The reported revenue represents a surprise of +1.98% over the Zacks Consensus Estimate of $55.19 million. With the consensus EPS estimate being -$0.02, the EPS surprise was -50%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Health Catalyst performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Professional services: $15.6 million compared to the $12.14 million average estimate based on two analysts. The reported number represents a change of -35.7% year over year.
• Revenue- Technology: $40.69 million versus $43.07 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -21.8% change.
• Adjusted Gross Profit- Professional Services: $0.27 million versus the two-analyst average estimate of $0.67 million.
• Adjusted Gross Profit- Technology: $24.65 million compared to the $24.66 million average estimate based on two analysts.

View all Key Company Metrics for Health Catalyst here>>>

Shares of Health Catalyst have returned -9.7% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.